Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-090845
Filing Date
2024-08-19
Accepted
2024-08-19 16:15:16
Documents
1
Period of Report
2024-08-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2422049-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2422049-1_3seq1.xml 3 1520
  Complete submission text file 0001104659-24-090845.txt   3158
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5005 MCCONNELL AVENUE LOS ANGELES CA 90066
Business Address
House David Duane (Reporting) CIK: 0002034219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37544 | Film No.: 241220723